Modified OVA mRNA
|Description||OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 5’ end. Sequences have been optimized to yield improved stability and performance.|
|Concentration||1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4.|
|mRNA length||1375 nt.|
|Applications||OVA mRNAs have been designed to produce high expression level of Ovalbumin protein.|
For research use only. Not intended for any clinical use.